
To support your AMCP chapter in preparing for a successful leadership transition, current SPC Chair Ryan Shan and past SPC members Logan Anderson and Macy Meng have created a short, informative video along with downloadable resources.
The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
For more disease state research, view the Market Insights Program.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.